Am80 induces neuronal differentiation via increased tropomyosin-related kinase B expression in a human neuroblastoma SH-SY5Y cell line

Biomedical Research (Japan)

Volumn 33, Issue 5, 2012, Pages 291-297

  Shiohira, Hideo ^a,b   Kitaoka, Akira ^a   Enjoji, Munechika ^a   Uno, Tsukasa ^b   Nakashima, Manabu ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CELL MARKER; MESSENGER RNA; NEUROMODULIN; PHOSPHOTRANSFERASE; RETINOID; TAMIBAROTENE; TROPOMYOSIN RELATED KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GAP43 GENE; GENE; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA; PROTEIN EXPRESSION;

BENZOATES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; GAP-43 PROTEIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEURITES; NEUROBLASTOMA; RECEPTOR, TRKB; TETRAHYDRONAPHTHALENES;

EID: 84869044097     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.33.291     Document Type: Article

References (19)

1. Alvarez S, Bourguet W, Gronemeyer H and de Lera AR (2011) Retinoic acid receptor modulators: a perspective on recent advances and promises. Expert Opin Ther Pat 21, 55-63.
2. Encinas M, Iglesias M, Llecha N and Comella JX (1999) Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 73, 1409-1421.
3. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Ceña V, Gallego C and Comella JX (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75, 991-1003.
4. Esposito CL, D'Alessio A, de Franciscis V and Cerchia L (2008) A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. PLoS One 3, e1643.
5. Ishida S, Shigemoto-Mogami Y, Shinozaki Y, Kagechika H, Shudo K, Ozawa S, Sawada J, Ohno Y and Inoue K (2004) Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol 68, 2177-2186.
6. Jämsä A, Hasslund K, Cowburn RF, Bäckström A and Vasänge M (2004) The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation. Biochem Biophys Res Commun 319, 993-1000.
7. Klein R, Lamballe F, Bryant S and Barbacid M (1992) The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron 8, 947-956.
8. Lo-Coco F and Ammatuna E (2006) The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Hematology Am Soc Hematol Educ Program 514, 156-161.
9. Maden M (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8, 755-765.
10. Middlemas DS, Kihl BK, Zhou J and Zhu X (1999) Brainderived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J Biol Chem 274, 16451-16460.
11. Ohnishi K (2007) PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int J Clin Oncol 12, 313-317.
12. Piu F, Gauthier NK, Olsson R, Currier EA, Lund BW, Croston GE, Hacksell U and Brann MR (2005) Identification of novel subtype selective RAR agonists. Biochem Pharmacol 71, 156-162.
13. Ruiz-León Y and Pascual A (2003) Induction of tyrosine kinase receptor b by retinoic acid allows brain-derived neurotrophic factor-induced amyloid precursor protein gene expression in human SH-SY5Y neuroblastoma cells. Neuroscience 120, 1019-1026.
14. Saeed S, Logie C, Stunnenberg HG and Martens JH (2011) Genome-wide functions of PML-RARα in acute promyelocytic leukaemia. Br J Cancer 104, 554-548.
15. Shiohira H, Kitaoka A, Shirasawa H, Enjoji M and Nakashima M (2010) Am80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line. Int J Mol Med 26, 393-399.
16. Takenaga M, Ohta Y, Tokura Y, Hamaguchi A, Shudo K, Okano H and Igarashi R (2009) The effect of Am-80, a synthetic retinoid, on spinal cord injury-induced motor dysfunction in rats. Biol Pharm Bull 32, 225-231.
17. Wong LF, Yip PK, Battaglia A, Grist J, Corcoran J, Maden M, Azzouz M, Kingsman SM, Kingsman AJ, Mazarakis ND and McMahon SB (2006) Retinoic acid receptor beta2 promotes functional regeneration of sensory axons in the spinal cord. Nat Neurosci 9, 243-250.
18. Yip PK, Wong LF, Pattinson D, Battaglia A, Grist J, Bradbury EJ, Maden M, McMahon SB and Mazarakis ND (2006) Lentiviral vector expressing retinoic acid receptor beta2 promotes recovery of function after corticospinal tract injury in the adult rat spinal cord. Hum Mol Genet 15, 3107-3118.
19. Zhou GB, Zhang J, Wang ZY, Chen SJ and Chen Z (2007) Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Philos Trans R Soc Lond B Biol Sci 362, 959-971.